Merck & Co., Inc.
- SEC CIK
- 0000310158
- Latest filing
- Aug 7, 2026
XLO holding history
Xilio Therapeutics, Inc. in every 13F filed by Merck & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
XLO overviewAll 13F holders of XLOFull Q2 2026 holdings
- Shares (Q2 2026)
- 105,982
- Value
- $1.02M
- % of portfolio
- 0.2%
- Quarters held
- 7
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 105,982 | $1.02M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 105,982 | $891.3K | 0.3% | 00.0% | UnchangedConverted for a 1-for-14 split | Holders |
| Q4 2025 | 1,483,758 | $949.9K | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1,483,758 | $1.25M | 0.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,483,758 | $1.01M | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1,483,758 | $1.07M | 0.7% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,483,758 | $1.42M | 0.5% | – | No prior filing | Holders |